Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pulmatrix, Inc.    PULM

PULMATRIX, INC.

(PULM)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

PULMATRIX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
11/04/2019 | 09:45am EST

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officer.

On November 1, 2019, the board of directors of the Company (the "Board") appointed Richard Batycky as a Class I director, to serve for a term expiring at the next annual meeting of the Company's stockholders at which the term of the Class I directors expires or until his successor is duly elected and qualified, or his earlier death, resignation or removal. The Board also appointed Mr. Batycky to serve on the Audit and Compensation Committees.

On November 4, 2019, the Company issued a press release announcing Mr. Batycky's appointment. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.


(d) Exhibits



               Exhibit
               Number    Description
               99.1        Press Release, dated November 4, 2019

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on PULMATRIX, INC.
01/30PULMATRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/30PULMATRIX : Receives Fast Track Designation for Pulmazole for the Treatment of A..
PR
01/16PULMATRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/16PULMATRIX : Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR
01/13PULMATRIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
01/06PULMATRIX : Announces Research Collaboration with Nocion Therapeutics to Explore..
PR
01/02PULMATRIX, INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
01/02PULMATRIX : Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Init..
PR
2019PULMATRIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2019PULMATRIX, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news